Accueil>>Signaling Pathways>> GPCR/G protein>> Glucocorticoid Receptor>>AZD5423

AZD5423

Catalog No.GC64949

AZD5423 est un modulateur inhalé, puissant, sélectif et non stéroÏdien des récepteurs des glucocorticoÏdes (GR) (SGRM).

Products are for research use only. Not for human use. We do not sell to patients.

AZD5423 Chemical Structure

Cas No.: 1034148-04-3

Taille Prix Stock Qté
10mM (in 1mL DMSO)
107,00 $US
En stock
5mg
117,00 $US
En stock
10mg
198,00 $US
En stock
50mg
594,00 $US
En stock
100mg
990,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

AZD5423 is an inhaled, potent, selective, and non-steroidal glucocorticoid receptor (GR) modulator (SGRM)[1]. AZD5423 effectively reduces allergen-induced responses in subjects with mild allergic asthma[2].

The affinity of AZD5423 to the glucocorticoid receptor is high with an IC50 of 0.9 nM in a radioligand human glucocorticoid receptor assay, and selectivity towards other steroid hormone receptors is >900-fold[1].

[1]. WerkstrÖm V, et al. Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator AZD5423 after Inhalation in Healthy Volunteers. Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):574-581.
[2]. Gauvreau GM, et al. A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses. Am J Respir Crit Care Med. 2015 Jan 15;191(2):161-7.

Avis

Review for AZD5423

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AZD5423

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.